niacinamide and sb 202190

niacinamide has been researched along with sb 202190 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Del Rio, A; Grossi, V; Ingravallo, G; Liuzzi, M; Martelli, N; Murzilli, S; Napoli, A; Simone, C	1

Other Studies

1 other study(ies) available for niacinamide and sb 202190

Article	Year
Sorafenib inhibits p38α activity in colorectal cancer cells and synergizes with the DFG-in inhibitor SB202190 to increase apoptotic response. Cancer biology & therapy, 2012, Volume: 13, Issue:14 Topics: Animals; Apoptosis; Caspase 3; Cell Line, Tumor; Colorectal Neoplasms; Drug Synergism; Female; Humans; Imidazoles; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 14; Neoplasm Transplantation; Niacinamide; Phenylurea Compounds; Pyridines; Signal Transduction; Sorafenib; Transplantation, Heterologous	2012

Article

Year

Sorafenib inhibits p38α activity in colorectal cancer cells and synergizes with the DFG-in inhibitor SB202190 to increase apoptotic response.

Cancer biology & therapy, 2012, Volume: 13, Issue:14

Topics: Animals; Apoptosis; Caspase 3; Cell Line, Tumor; Colorectal Neoplasms; Drug Synergism; Female; Humans; Imidazoles; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 14; Neoplasm Transplantation; Niacinamide; Phenylurea Compounds; Pyridines; Signal Transduction; Sorafenib; Transplantation, Heterologous

2012